IOL CHEMICALS & PHARM. | PROCTER & GAMBLE HEALTH | IOL CHEMICALS & PHARM./ PROCTER & GAMBLE HEALTH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | 35.2 | 38.5% | View Chart |
P/BV | x | 1.5 | 10.7 | 14.3% | View Chart |
Dividend Yield | % | 1.0 | 2.0 | 51.1% |
IOL CHEMICALS & PHARM. PROCTER & GAMBLE HEALTH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
PROCTER & GAMBLE HEALTH Jun-23 |
IOL CHEMICALS & PHARM./ PROCTER & GAMBLE HEALTH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 5,366 | 10.0% | |
Low | Rs | 272 | 3,883 | 7.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 740.7 | 51.0% | |
Earnings per share (Unadj.) | Rs | 23.7 | 138.2 | 17.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 155.2 | 20.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 95.00 | 4.2% | |
Avg Dividend yield | % | 1.0 | 2.1 | 48.1% | |
Book value per share (Unadj.) | Rs | 256.8 | 447.6 | 57.4% | |
Shares outstanding (eoy) | m | 58.71 | 16.60 | 353.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 6.2 | 17.2% | |
Avg P/E ratio | x | 17.1 | 33.5 | 51.0% | |
P/CF ratio (eoy) | x | 12.8 | 29.8 | 43.0% | |
Price / Book Value ratio | x | 1.6 | 10.3 | 15.2% | |
Dividend payout | % | 16.9 | 68.7 | 24.6% | |
Avg Mkt Cap | Rs m | 23,743 | 76,761 | 30.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 2,062 | 81.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 12,296 | 180.3% | |
Other income | Rs m | 256 | 184 | 139.3% | |
Total revenues | Rs m | 22,427 | 12,480 | 179.7% | |
Gross profit | Rs m | 2,257 | 3,247 | 69.5% | |
Depreciation | Rs m | 462 | 281 | 164.3% | |
Interest | Rs m | 165 | 8 | 2,139.0% | |
Profit before tax | Rs m | 1,887 | 3,142 | 60.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 847 | 58.4% | |
Profit after tax | Rs m | 1,391 | 2,295 | 60.6% | |
Gross profit margin | % | 10.2 | 26.4 | 38.5% | |
Effective tax rate | % | 26.2 | 27.0 | 97.3% | |
Net profit margin | % | 6.3 | 18.7 | 33.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 11,713 | 82.5% | |
Current liabilities | Rs m | 5,025 | 6,791 | 74.0% | |
Net working cap to sales | % | 20.9 | 40.0 | 52.3% | |
Current ratio | x | 1.9 | 1.7 | 111.5% | |
Inventory Days | Days | 43 | 263 | 16.5% | |
Debtors Days | Days | 8 | 343 | 2.4% | |
Net fixed assets | Rs m | 11,017 | 10,617 | 103.8% | |
Share capital | Rs m | 587 | 166 | 353.7% | |
"Free" reserves | Rs m | 14,490 | 7,265 | 199.5% | |
Net worth | Rs m | 15,077 | 7,431 | 202.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 22,330 | 92.6% | |
Interest coverage | x | 12.5 | 409.1 | 3.0% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.6 | 194.7% | |
Return on assets | % | 7.5 | 10.3 | 73.0% | |
Return on equity | % | 9.2 | 30.9 | 29.9% | |
Return on capital | % | 13.6 | 42.4 | 32.1% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 13.1 | 0.0% | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | 1,605 | 0.0% | |
Fx inflow | Rs m | 5,930 | 1,465 | 404.7% | |
Fx outflow | Rs m | 6,052 | 1,605 | 377.0% | |
Net fx | Rs m | -122 | -140 | 86.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 2,360 | 51.8% | |
From Investments | Rs m | -1,200 | -215 | 558.1% | |
From Financial Activity | Rs m | -41 | -985 | 4.2% | |
Net Cashflow | Rs m | -18 | 1,160 | -1.6% |
Indian Promoters | % | 48.2 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 51.8 | - | |
Indian inst/Mut Fund | % | 1.7 | 20.0 | 8.5% | |
FIIs | % | 1.4 | 6.2 | 22.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 48.2 | 107.5% | |
Shareholders | 130,003 | 56,778 | 229.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Procter & Gamble Health | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.49% | 2.12% | -0.17% |
1-Month | 4.61% | 0.43% | 0.48% |
1-Year | -0.40% | 2.20% | 52.79% |
3-Year CAGR | -13.27% | -8.80% | 14.19% |
5-Year CAGR | 16.08% | 4.98% | 19.23% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Procter & Gamble Health share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Procter & Gamble Health.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Procter & Gamble Health.
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded higher on Tuesday following overnight gain on Wall Street.